NO309273B1 - Ascomyciner, anvendelse av samme for fremstilling av medikament samt farmasöytisk preparat innbefattende samme - Google Patents

Ascomyciner, anvendelse av samme for fremstilling av medikament samt farmasöytisk preparat innbefattende samme Download PDF

Info

Publication number
NO309273B1
NO309273B1 NO974536A NO974536A NO309273B1 NO 309273 B1 NO309273 B1 NO 309273B1 NO 974536 A NO974536 A NO 974536A NO 974536 A NO974536 A NO 974536A NO 309273 B1 NO309273 B1 NO 309273B1
Authority
NO
Norway
Prior art keywords
alkoxycarbonyl
alkyl
treatment
compound according
ascomycins
Prior art date
Application number
NO974536A
Other languages
English (en)
Norwegian (no)
Other versions
NO974536D0 (no
NO974536L (no
Inventor
Rene Hersperger
Reto Naef
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO974536D0 publication Critical patent/NO974536D0/no
Publication of NO974536L publication Critical patent/NO974536L/no
Publication of NO309273B1 publication Critical patent/NO309273B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
NO974536A 1995-04-06 1997-10-01 Ascomyciner, anvendelse av samme for fremstilling av medikament samt farmasöytisk preparat innbefattende samme NO309273B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds
PCT/EP1996/001492 WO1996031514A1 (en) 1995-04-06 1996-04-04 Ascomycins

Publications (3)

Publication Number Publication Date
NO974536D0 NO974536D0 (no) 1997-10-01
NO974536L NO974536L (no) 1997-10-01
NO309273B1 true NO309273B1 (no) 2001-01-08

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974536A NO309273B1 (no) 1995-04-06 1997-10-01 Ascomyciner, anvendelse av samme for fremstilling av medikament samt farmasöytisk preparat innbefattende samme

Country Status (21)

Country Link
US (1) US5925649A (cs)
EP (1) EP0819130A1 (cs)
JP (1) JP2000505044A (cs)
KR (1) KR19980703583A (cs)
CN (1) CN1088068C (cs)
AR (1) AR004480A1 (cs)
AU (1) AU703523B2 (cs)
BR (1) BR9604808A (cs)
CA (1) CA2216562A1 (cs)
CO (1) CO4750668A1 (cs)
CZ (1) CZ312397A3 (cs)
FI (1) FI973529A7 (cs)
HU (1) HUP9801993A3 (cs)
IL (1) IL117815A (cs)
MX (1) MX9707636A (cs)
NO (1) NO309273B1 (cs)
NZ (1) NZ307170A (cs)
PL (1) PL322553A1 (cs)
SK (1) SK133997A3 (cs)
TR (1) TR199700999T1 (cs)
WO (1) WO1996031514A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570814B (en) 1998-03-26 2004-01-11 Fujisawa Pharmaceutical Co Sustained-release pharmaceutical composition
TR200003108T2 (tr) * 1998-04-27 2001-02-21 Fujisawa Pharmaceutical Co., Ltd. İlaç kompozisyonları
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
CA2372448A1 (en) * 1999-04-30 2000-11-09 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
AU769315B2 (en) 1999-08-24 2004-01-22 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
AU2002256507A1 (en) * 2001-05-09 2002-11-18 Novartis Ag Methods for selective immunomodulation using pimecrolimus
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
US20060035879A1 (en) * 2002-11-15 2006-02-16 Prescott Margaret F Organic Compounds
AU2004212264B9 (en) * 2003-02-17 2009-11-26 Cipla Limited Pharmaceutical patch
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
EP1699456A1 (en) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
EP3977995A1 (en) 2014-10-28 2022-04-06 Koushi Yamaguchi Tacrolimus for ameliorating pregnancy conditions
JP7465806B2 (ja) 2018-08-10 2024-04-11 晃史 山口 母体と胎児との関係における液性免疫関連疾患の治療薬
JPWO2020129348A1 (ja) 2018-12-18 2021-11-04 晃史 山口 不妊・不育症または妊娠状態を改善するための薬剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
EP0487593A1 (en) * 1989-08-18 1992-06-03 FISONS plc Macrocyclic compounds
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
JPH05504956A (ja) * 1990-03-12 1993-07-29 藤沢薬品工業株式会社 トリシクロ化合物
JPH05507915A (ja) * 1990-06-11 1993-11-11 藤沢薬品工業株式会社 特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのｆｋ５０６等のマクロライド化合物の用途
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
EP0474126B1 (en) * 1990-09-04 1997-03-19 Fujisawa Pharmaceutical Co., Ltd. Ointments containing tricyclic compound
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
CZ289773B6 (cs) * 1994-10-26 2002-04-17 Novartis Ag Farmaceutický prostředek pro místní aplikaci

Also Published As

Publication number Publication date
KR19980703583A (ko) 1998-11-05
FI973529A0 (fi) 1997-08-27
PL322553A1 (en) 1998-02-02
HUP9801993A2 (hu) 1998-12-28
US5925649A (en) 1999-07-20
CN1180359A (zh) 1998-04-29
AR004480A1 (es) 1998-12-16
WO1996031514A1 (en) 1996-10-10
NO974536D0 (no) 1997-10-01
MX9707636A (es) 1998-06-30
HUP9801993A3 (en) 2000-04-28
CA2216562A1 (en) 1996-10-10
IL117815A (en) 2000-07-16
EP0819130A1 (en) 1998-01-21
AU5645396A (en) 1996-10-23
CO4750668A1 (es) 1999-03-31
BR9604808A (pt) 1998-06-09
NO974536L (no) 1997-10-01
JP2000505044A (ja) 2000-04-25
TR199700999T1 (xx) 1998-01-21
NZ307170A (en) 1999-03-29
SK133997A3 (en) 1998-05-06
CZ312397A3 (cs) 1998-01-14
CN1088068C (zh) 2002-07-24
FI973529L (fi) 1997-11-25
IL117815A0 (en) 1996-08-04
AU703523B2 (en) 1999-03-25
FI973529A7 (fi) 1997-11-25

Similar Documents

Publication Publication Date Title
NO309273B1 (no) Ascomyciner, anvendelse av samme for fremstilling av medikament samt farmasöytisk preparat innbefattende samme
US5486523A (en) Carbamates of rapamycin
US9745335B2 (en) N-substituted second generation derivatives of antifungal antibiotic amphotericin B and methods of their preparation and application
NO20121113L (no) Stabilisering av makrolider
PT765329E (pt) Amidinocarbamatos de rapamicina e composicoes farmaceuticas que os contem
US20060247216A1 (en) Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
AU2012395673A1 (en) Rapamycin analogs and methods for making same
CZ285421B6 (cs) Nové cyklosporiny
EP4483876A1 (en) Use of indazole compound for treating psoriasis
CN110536894A (zh) 作为fxr调节剂的阿维菌素(avermectin)衍生物
EP3898645B1 (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
CN100398544C (zh) 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
US5266566A (en) Method of treating fungal infections using sterodial ester compounds
EP3299381B1 (en) Water soluble rapamycin derivative
CZ20013712A3 (cs) Pouľití maduraftalazinových derivátů jako inhibitorů prozánětlivých cytokinů
RU2173688C2 (ru) Аскомицины, способ их получения и фармацевтическая композиция на их основе
EP2852601A1 (en) Semisynthetic derivatives of nystatin a1
EP1974739A1 (en) Methods and compounds for modulating inflammatory processes
CN117562915A (zh) 一种腺苷衍生物在制备预防、缓解或治疗纤维化疾病的药物中的应用
AU760232B2 (en) Benzopyran-containing compounds and method for their use
AU607621B2 (en) Novel esters of estramustine
HK1158204B (en) Vigor enhancement via administration of pyrimidine derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2003